{"id":"https://openalex.org/W2097457247","doi":"https://doi.org/10.1001/jama.2010.993","title":"Use of Generic Antiretroviral Agents and Cost Savings in PEPFAR Treatment Programs","display_name":"Use of Generic Antiretroviral Agents and Cost Savings in PEPFAR Treatment Programs","publication_year":2010,"publication_date":"2010-07-18","ids":{"openalex":"https://openalex.org/W2097457247","doi":"https://doi.org/10.1001/jama.2010.993","mag":"2097457247","pmid":"https://pubmed.ncbi.nlm.nih.gov/20639565"},"language":"en","primary_location":{"id":"doi:10.1001/jama.2010.993","doi":"https://doi.org/10.1001/jama.2010.993","is_oa":false,"landing_page_url":"https://doi.org/10.1001/jama.2010.993","pdf_url":null,"source":{"id":"https://openalex.org/S172573765","display_name":"JAMA","issn_l":"0002-9955","issn":["0002-9955","0098-7484","1538-3598","2376-8118"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320259","host_organization_name":"American Medical Association","host_organization_lineage":["https://openalex.org/P4310320259"],"host_organization_lineage_names":["American Medical Association"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JAMA","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5086465511","display_name":"Charles B. Holmes","orcid":"https://orcid.org/0000-0002-7924-6761","observed_orcids":["https://orcid.org/0000-0002-7924-6761"]},"institutions":[{"id":"https://openalex.org/I1340685415","display_name":"United States Department of State","ror":"https://ror.org/03vvynj75","country_code":"US","type":"government","lineage":["https://openalex.org/I1340685415"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Charles B. Holmes","raw_affiliation_strings":["Office of the US Global AIDS Coordinator, US Department of State, Washington, DC 20522-2920, USA. holmescb@state.gov"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Office of the US Global AIDS Coordinator, US Department of State, Washington, DC 20522-2920, USA. holmescb@state.gov","institution_ids":["https://openalex.org/I1340685415"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5086465511"],"corresponding_institution_ids":["https://openalex.org/I1340685415"],"apc_list":null,"apc_paid":null,"fwci":30.2928,"has_fulltext":false,"cited_by_count":85,"citation_normalized_percentile":{"value":0.99554333,"is_in_top_1_percent":true,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":100},"biblio":{"volume":"304","issue":"3","first_page":"313","last_page":"313"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11792","display_name":"Pharmaceutical Economics and Policy","score":0.9023000001907349,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},"topics":[{"id":"https://openalex.org/T11792","display_name":"Pharmaceutical Economics and Policy","score":0.9023000001907349,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T14334","display_name":"HIV/AIDS Impact and Responses","score":0.05050000175833702,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T10082","display_name":"HIV/AIDS Research and Interventions","score":0.033399999141693115,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/generic-antiretroviral-drugs","display_name":"generic antiretroviral drugs","score":0.9620000123977661},{"id":"https://openalex.org/keywords/antiretroviral-therapy","display_name":"antiretroviral therapy","score":0.9100000262260437},{"id":"https://openalex.org/keywords/pepfar","display_name":"PEPFAR","score":0.8999999761581421},{"id":"https://openalex.org/keywords/pharmaceutical-procurement","display_name":"drug procurement","score":0.6700000166893005},{"id":"https://openalex.org/keywords/cost-reduction","display_name":"cost reduction","score":0.6679999828338623},{"id":"https://openalex.org/keywords/fixed-dose-combination","display_name":"fixed-dose combination","score":0.6570000052452087},{"id":"https://openalex.org/keywords/generic-drug-approval","display_name":"generic drug approval","score":0.5950000286102295},{"id":"https://openalex.org/keywords/drug-expenditure","display_name":"drug expenditure","score":0.5019999742507935},{"id":"https://openalex.org/keywords/developing-countries","display_name":"developing countries","score":0.4099999964237213},{"id":"https://openalex.org/keywords/south-africa","display_name":"South Africa","score":0.46399998664855957},{"id":"https://openalex.org/keywords/vietnam","display_name":"Vietnam","score":0.4659999907016754},{"id":"https://openalex.org/keywords/haiti","display_name":"Haiti","score":0.32499998807907104},{"id":"https://openalex.org/keywords/guyana","display_name":"Guyana","score":0.7620000243186951},{"id":"https://openalex.org/keywords/africa","display_name":"Africa","score":0.5249999761581421},{"id":"https://openalex.org/keywords/latin-america","display_name":"Latin America","score":0.46299999952316284},{"id":"https://openalex.org/keywords/caribbean","display_name":"Caribbean","score":0.41499999165534973},{"id":"https://openalex.org/keywords/asia","display_name":"Asia","score":0.34700000286102295},{"id":"https://openalex.org/keywords/pacific-islands","display_name":"Pacific Islands","score":0.36500000953674316}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9129433631896973},{"id":"https://openalex.org/C201650216","wikidata":"https://www.wikidata.org/wiki/Q829492","display_name":"Procurement","level":2,"score":0.684064507484436},{"id":"https://openalex.org/C83864248","wikidata":"https://www.wikidata.org/wiki/Q177323","display_name":"Developing country","level":2,"score":0.5513755679130554},{"id":"https://openalex.org/C44249647","wikidata":"https://www.wikidata.org/wiki/Q208498","display_name":"Confidence interval","level":2,"score":0.5164458751678467},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.4834928810596466},{"id":"https://openalex.org/C2776396487","wikidata":"https://www.wikidata.org/wiki/Q506319","display_name":"Generic drug","level":3,"score":0.4588959217071533},{"id":"https://openalex.org/C3013748606","wikidata":"https://www.wikidata.org/wiki/Q15787","display_name":"Human immunodeficiency virus (HIV)","level":2,"score":0.4276611804962158},{"id":"https://openalex.org/C512399662","wikidata":"https://www.wikidata.org/wiki/Q3505712","display_name":"Family medicine","level":1,"score":0.3360099196434021},{"id":"https://openalex.org/C50522688","wikidata":"https://www.wikidata.org/wiki/Q189833","display_name":"Economic growth","level":1,"score":0.20287591218948364},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.13756456971168518},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.10752281546592712},{"id":"https://openalex.org/C162853370","wikidata":"https://www.wikidata.org/wiki/Q39809","display_name":"Marketing","level":1,"score":0.09512948989868164},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.08881011605262756},{"id":"https://openalex.org/C144133560","wikidata":"https://www.wikidata.org/wiki/Q4830453","display_name":"Business","level":0,"score":0.0834554135799408},{"id":"https://openalex.org/C162324750","wikidata":"https://www.wikidata.org/wiki/Q8134","display_name":"Economics","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D000349","descriptor_name":"Africa","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003625","descriptor_name":"Data Collection","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005102","descriptor_name":"Health Expenditures","qualifier_ui":"Q000706","qualifier_name":"statistics & numerical data","is_major_topic":false},{"descriptor_ui":"D006172","descriptor_name":"Guyana","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006205","descriptor_name":"Haiti","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014481","descriptor_name":"United States","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014486","descriptor_name":"United States Food and Drug Administration","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014744","descriptor_name":"Vietnam","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015658","descriptor_name":"HIV Infections","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D016527","descriptor_name":"Drug Costs","qualifier_ui":"Q000706","qualifier_name":"statistics & numerical data","is_major_topic":false},{"descriptor_ui":"D016568","descriptor_name":"Drugs, Generic","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":true},{"descriptor_ui":"D016568","descriptor_name":"Drugs, Generic","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D017046","descriptor_name":"Cost Savings","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017277","descriptor_name":"Drug Approval","qualifier_ui":"Q000331","qualifier_name":"legislation & jurisprudence","is_major_topic":false},{"descriptor_ui":"D044966","descriptor_name":"Anti-Retroviral Agents","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":true},{"descriptor_ui":"D044966","descriptor_name":"Anti-Retroviral Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1001/jama.2010.993","doi":"https://doi.org/10.1001/jama.2010.993","is_oa":false,"landing_page_url":"https://doi.org/10.1001/jama.2010.993","pdf_url":null,"source":{"id":"https://openalex.org/S172573765","display_name":"JAMA","issn_l":"0002-9955","issn":["0002-9955","0098-7484","1538-3598","2376-8118"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320259","host_organization_name":"American Medical Association","host_organization_lineage":["https://openalex.org/P4310320259"],"host_organization_lineage_names":["American Medical Association"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JAMA","raw_type":"journal-article"},{"id":"pmid:20639565","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/20639565","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JAMA","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9391000270843506}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":12,"referenced_works":["https://openalex.org/W1935318831","https://openalex.org/W2032659188","https://openalex.org/W2056631580","https://openalex.org/W2082454031","https://openalex.org/W2113017588","https://openalex.org/W2127868085","https://openalex.org/W2162445884","https://openalex.org/W2288781812","https://openalex.org/W2740563592","https://openalex.org/W2952339263","https://openalex.org/W4233106339","https://openalex.org/W4243851420"],"related_works":["https://openalex.org/W2578647363","https://openalex.org/W2072507851","https://openalex.org/W2051311003","https://openalex.org/W4392340984","https://openalex.org/W2833597448","https://openalex.org/W2160228909","https://openalex.org/W2782738471","https://openalex.org/W1967855332","https://openalex.org/W2809787169","https://openalex.org/W1967854506"],"abstract_inverted_index":{"CONTEXT:":[0],"One":[1],"of":[2,10,20,25,40,49,71,106,141,206,240,258,303,313],"the":[3,7,14,18,57,69,204,249],"biggest":[4],"hurdles":[5],"to":[6,35,104,122,162,172,193,218,270],"rapid":[8],"scale-up":[9],"antiretroviral":[11,21],"therapy":[12],"in":[13,45,77,84,90,109,191,198,216,223,243,268,275,287,290,293,297,309],"developing":[15],"world":[16],"was":[17,316],"price":[19],"drugs":[22],"(ARVs).":[23],"Modification":[24],"an":[26],"existing":[27],"US":[28,58],"Food":[29],"and":[30,38,81,86,93,115,132,146,148,166,203,295,322],"Drug":[31,128],"Administration":[32],"(FDA)":[33],"process":[34],"expedite":[36],"review":[37],"approval":[39],"generic":[41,72,142,152,181,207,244,251,259,282,314],"ARVs":[42,52,73,107,182,315],"quickly":[43],"resulted":[44],"a":[46,137,299],"large":[47],"number":[48],"FDA-tentatively":[50],"approved":[51],"available":[53],"for":[54,62],"use":[55,92,284],"by":[56,112],"President's":[59],"Emergency":[60],"Plan":[61],"AIDS":[63],"Relief":[64],"(PEPFAR).":[65],"OBJECTIVE:":[66],"To":[67],"evaluate":[68],"uptake":[70],"among":[74],"PEPFAR-supported":[75,307],"programs":[76,234,308],"Guyana,":[78],"Haiti,":[79],"Vietnam,":[80],"13":[82],"countries":[83,111],"Africa,":[85],"changes":[87],"over":[88],"time":[89],"ARV":[91,130,155,241,283,320],"costs.":[94],"DESIGN,":[95],"SETTING,":[96],"AND":[97],"PARTICIPANTS:":[98],"An":[99],"annual":[100],"survey":[101],"from":[102,151,158,169,184,211,263],"2005":[103,192,217,269],"2008":[105,199,224],"purchased":[108],"16":[110,310],"PEPFAR":[113,120,233],"implementing":[114],"procurement":[116,143,167,252,321],"partners":[117],"(organizations":[118],"using":[119],"funding":[121],"purchase":[123],"ARVs).":[124],"MAIN":[125],"OUTCOME":[126],"MEASURES:":[127],"expenditures,":[129],"types":[131],"volumes":[133],"(assessed":[134],"per":[135],"pack,":[136],"1-month":[138],"supply),":[139],"proportion":[140,178,205],"across":[144],"years":[145],"countries,":[147,311],"cost":[149,325],"savings":[150,279,302],"procurement.":[153],"RESULTS:":[154],"expenditures":[156],"increased":[157,168,183,210,262,319],"$116.8":[159],"million":[160,164,171,174],"(2005)":[161],"$202.2":[163],"(2008);":[165],"6.2":[170],"22.1":[173],"monthly":[175],"packs.":[176],"The":[177],"spent":[179],"on":[180],"9.17%":[185],"(95%":[186,195,213,220,265,272],"confidence":[187],"interval":[188],"[CI],":[189],"9.17%-9.18%)":[190],"76.41%":[194],"CI,":[196,214,221,255,266,273],"76.41%-76.42%)":[197],"(P":[200,225],"<":[201,226],".001),":[202],"packs":[208,242],"procured":[209,236],"14.8%":[212],"14.79%-14.84%)":[215],"89.33%":[219],"89.32%-89.34%)":[222],".001).":[227],"In":[228],"2008,":[229,298],"there":[230],"were":[231,285],"8":[232],"that":[235],"at":[237],"least":[238],"90.0%":[239],"form;":[245],"South":[246],"Africa":[247],"had":[248],"lowest":[250],"(24.7%;":[253],"95%":[254],"24.6%-24.8%).":[256],"Procurement":[257],"fixed-dose":[260],"combinations":[261],"33.3%":[264],"33.24%-33.43%)":[267],"42.73%":[271],"42.71%-42.75%)":[274],"2008.":[276],"Estimated":[277],"yearly":[278],"generated":[280],"through":[281],"$8,108,444":[286],"2005,":[288],"$24,940,014":[289],"2006,":[291],"$75,645,816":[292],"2007,":[294],"$214,648,982":[296],"total":[300],"estimated":[301,324],"$323,343,256.":[304],"CONCLUSION:":[305],"Among":[306],"availability":[312],"associated":[317],"with":[318],"substantial":[323],"savings.":[326]},"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":1},{"year":2020,"cited_by_count":3},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":9},{"year":2016,"cited_by_count":4},{"year":2015,"cited_by_count":7},{"year":2014,"cited_by_count":9},{"year":2013,"cited_by_count":14},{"year":2012,"cited_by_count":21}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2016-06-24T00:00:00"}